7-143299976-G-A
Variant names:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_032982.4(CASP2):c.801G>A(p.Thr267Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0014 in 1,614,116 control chromosomes in the GnomAD database, including 16 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0042 ( 6 hom., cov: 32)
Exomes 𝑓: 0.0011 ( 10 hom. )
Consequence
CASP2
NM_032982.4 synonymous
NM_032982.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.587
Genes affected
CASP2 (HGNC:1503): (caspase 2) This gene encodes a member of the cysteine-aspartic acid protease (caspase) family. Caspases mediate cellular apoptosis through the proteolytic cleavage of specific protein substrates. The encoded protein may function in stress-induced cell death pathways, cell cycle maintenance, and the suppression of tumorigenesis. Increased expression of this gene may play a role in neurodegenerative disorders including Alzheimer's disease, Huntington's disease and temporal lobe epilepsy. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jan 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 7-143299976-G-A is Benign according to our data. Variant chr7-143299976-G-A is described in ClinVar as [Benign]. Clinvar id is 710251.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.587 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 6 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CASP2 | NM_032982.4 | c.801G>A | p.Thr267Thr | synonymous_variant | Exon 7 of 11 | ENST00000310447.10 | NP_116764.2 | |
CASP2 | NM_001224.5 | c.708G>A | p.Thr236Thr | synonymous_variant | Exon 7 of 12 | NP_001215.1 | ||
CASP2 | NM_032983.4 | c.*256G>A | 3_prime_UTR_variant | Exon 6 of 10 | NP_116765.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00417 AC: 635AN: 152144Hom.: 7 Cov.: 32
GnomAD3 genomes
AF:
AC:
635
AN:
152144
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00190 AC: 477AN: 251486Hom.: 0 AF XY: 0.00173 AC XY: 235AN XY: 135920
GnomAD3 exomes
AF:
AC:
477
AN:
251486
Hom.:
AF XY:
AC XY:
235
AN XY:
135920
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00111 AC: 1620AN: 1461854Hom.: 10 Cov.: 32 AF XY: 0.00111 AC XY: 807AN XY: 727234
GnomAD4 exome
AF:
AC:
1620
AN:
1461854
Hom.:
Cov.:
32
AF XY:
AC XY:
807
AN XY:
727234
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00418 AC: 637AN: 152262Hom.: 6 Cov.: 32 AF XY: 0.00414 AC XY: 308AN XY: 74432
GnomAD4 genome
AF:
AC:
637
AN:
152262
Hom.:
Cov.:
32
AF XY:
AC XY:
308
AN XY:
74432
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
7
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
CASP2: BP4, BP7, BS2 -
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at